American Society of Hematology

ASH Urges the NIH to Protect the Future of Hematology Biomedical Research Workforce

Published on: October 20, 2011

In August, the National Institutes of Health (NIH) Working Group on the Future of Biomedical Research Workforce published a request for information seeking input about how to ensure the United States maintains a sustainable, diverse, and productive biomedical research workforce.

In its response, the Society cited the importance of the hematology workforce, noting that hematologists are currently working on some of the most costly and devastating medical problems that affect health care in the United States. Moreover, the Society noted that the vast majority of these important advances in hematology research and treatment of hematological diseases have all depended on support from the NIH.

The Society's recommendations to the work group include:

  • Any model for a sustainable, diverse, and productive U.S. biomedical research workforce should include biomedical research scientists from non-academic settings as well as doctoral graduates in non-research careers including science policy and science writing.
  • Increasing the funding of training grants to include more slots for PhDs, MD-PhDs, and MDs interested in biomedical research.
  • Changes to the PhD curriculum to provide training for multiple career paths (the "branching career pipeline").
  • Inclusion of provisions to protect research time for clinician-scientists and to create incentives for universities and hospitals to provide training and infrastructure support to these clinician-scientists.
  • Expanded access to R01 grants for clinician-scientists.

Read the Society's full response to the work group.

back to top